Nov. 24, 2020—Americans may be much more receptive to refugee settlement in the United States than current government immigration policies suggest, according to a new study by Mariano Sana, associate professor of sociology and a faculty affiliate of Vanderbilt’s influential Latin American Public Opinion Project.
Nov. 19, 2020—Modernized endoscopic system blends robotics and magnetic coupling to improve medical procedures, starting with colonoscopies.
Nov. 18, 2020—Interdisciplinary Earth scientists explore how little-understood underwater volcanoes affect the atmosphere.
Nov. 17, 2020—Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus.
Nov. 16, 2020—With a statistical network to model civil conflict, political scientist Cassy Dorff applies a data-based lens to understanding war and peace.
Nov. 12, 2020—Vanderbilt contributes molecular imaging data of kidney to the Human BioMolecular Atlas Program, a consortium of 18 diverse collaborative research teams across the United States and Europe.
Nov. 9, 2020—Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics.
Honey bees lose sleep after ingesting pesticides, leading to greater stress and lower hive survival rates
Nov. 5, 2020—Vanderbilt research shows the unintended consequence of pesticides is the death of a bee’s circadian rhythm, not the bee herself.
Spontaneous release of neurotransmitters in the brain identified as a culprit of developmental disorders in infants and children
Nov. 3, 2020—Vanderbilt researchers discover how a group of neurodevelopmental disorders ranging in severity are caused in infants and children, opening new avenues for therapeutics.
Nov. 2, 2020—Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.
Vanderbilt trans-institutional team shows how next-gen wearable sensor algorithms powered by machine learning could be key to preventing injuries that sideline runners
Oct. 28, 2020—An interdisciplinary team of researchers led by Karl Zelik explores how wearable sensor technology can monitor bone stress in runners, developing a new multi-sensor algorithm that could save runners from months of pain and recovery time.
Oct. 27, 2020—Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people.